Endomyocardial fibrosis as etiology of advanced heart failure. The relevance of a multi-imagine approach.

Authors

  • Elizabeth Figueroa Flores Departamento de Medicina Interna, Universidad de los Andes, Santiago, Chile.
  • Javiera Valencia Navech Departamento de Medicina Interna, Universidad de los Andes, Santiago, Chile.
  • Florencia Gaviraghi Gutierrez Escuela de Medicina, Universidad de los Andes. Santiago, Chile.
  • Óscar Moreno Urrutia Departamento de Cardiología y Cirugía Cardíaca, Clínica Dávila. Santiago, Chile. Escuela de Medicina, Universidad de los Andes. Santiago, Chile.
  • Cristobal Balmaceda Almeida Dr.

DOI:

https://doi.org/10.37615/retic.v7n2a7

Keywords:

endomyocardial fibrosis, restrictive cardiomyopathies

Abstract

Endomyocardial fibrosis belongs to the group of restrictive cardiomyopathies. Although it is a rare condition, it might have a progressive course, with limited treatment possibilities and finally, can progress to end-stage heart failure. In our case we present a 71-year-old man, with a progressive course to an advanced heart failure and we show how a multi-imaging approach was a cornerstone for the diagnosis, understanding the pathophysiology and the mechanisms involved in this disease.  

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. marzo de 1996;93(5):841-2.doi: https://doi.org/10.1161/01.cir.93.5.841. DOI: https://doi.org/10.1161/01.CIR.93.5.841

Grimaldi A, Mocumbi AO, Freers J, Lachaud M, Mirabel M, Ferreira B, et al. Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives. Circulation. 14 de junio de 2016;133(24):2503-15. doi: https://doi.org/10.1161/CIRCULATIONAHA.115.021178. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.021178

Tobar M, Basante R, Guerrero M. Fibrosis endomiocárdica crónica, reporte de caso en área no endémica. Rev Chil Cardiol. 2017;36(2):127-31. doi: https://doi.org/10.4067/S0718-85602017000200006. DOI: https://doi.org/10.4067/S0718-85602017000200006

Villamil-Munévar A, Barbosa C, Ternera-Barrios A, Pinedo JL, Olaya A. Fibrosis endomiocárdica. Revista Colombiana de Cardiología. enero de 2017;24(1):59. e1-59.e6. doi: https://doi.org/10.1016/j.rccar.2016.09.006. DOI: https://doi.org/10.1016/j.rccar.2016.09.006

Vasquez-Rodriguez JF, Medina-Mur R, Giraldo LE, Juan-Guardela ML, Gelves J, Jaimes CP. Fibrosis endomiocárdica: una cardiomiopatía restrictiva en países en vía de desarrollo. ACM. 25 de marzo de 2021;91(2):4619. doi: https://doi.org/10.24875/ACM.20000150. DOI: https://doi.org/10.24875/ACM.20000150

De Carvalho FP, Azevedo CF. Comprehensive Assessment of Endomyocardial Fibrosis with Cardiac MRI: Morphology, Function, and Tissue Characterization. RadioGraphics. marzo de 2020;40(2):336-53. doi: https://doi.org/10.1148/rg.2020190148 DOI: https://doi.org/10.1148/rg.2020190148

Published

2024-08-28

How to Cite

1.
Figueroa Flores E, Valencia Navech J, Gaviraghi Gutierrez F, Moreno Urrutia Óscar, Balmaceda Almeida C. Endomyocardial fibrosis as etiology of advanced heart failure. The relevance of a multi-imagine approach. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2024 Aug. 28 [cited 2024 Sep. 27];7(2):27-30. Available from: https://imagenretic.org/RevEcocarPract/article/view/567